🇺🇸 Colloidal Bismuth Subcitrate in United States
12 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 12
Most-reported reactions
- Pyrexia — 6 reports (50%)
- Adverse Event — 1 report (8.33%)
- Asthenia — 1 report (8.33%)
- Headache — 1 report (8.33%)
- Nausea — 1 report (8.33%)
- Vision Blurred — 1 report (8.33%)
- Vomiting — 1 report (8.33%)
Other Gastroenterology approved in United States
Frequently asked questions
Is Colloidal Bismuth Subcitrate approved in United States?
Colloidal Bismuth Subcitrate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Colloidal Bismuth Subcitrate in United States?
Sir Run Run Shaw Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.